Referencias Bibliográficas sobre Probióticos para Niños

World Gastroenterology Organisation, 2017.  Probióticos y prebióticos. Febrero de 2017

(1)Szajewska H, Canani RB, Guarino A, et al. Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children. J Pediatr Gastroenterol Nutr. 2016;62(3):495-506. doi:10.1097/MPG.0000000000001081

(2)Jirapinyo P, Densupsoontorn N, Thamonsiri N, et al. Prevention of antibiotic-associated diarrhea in infants by probiotics. J Med Assoc Thai 2002;85(Suppl 2):S739-42.

(4)Lönnermark E, Friman V, Lappas G, Sandberg T, Berggren A, Adlerberth I. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol. 2010;44(2):106-112. doi:10.1097/MCG.0b013e3181b2683f

(3)Corrêa NB, Péret Filho LA, Penna FJ, Lima FM, Nicoli JR. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J Clin Gastroenterol. 2005;39(5):385-389. doi:10.1097/01.mcg.0000159217.47419.5b

(5)Eskesen D, Jespersen L, Michelsen B, et al. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12(R), on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr. 2015;114:1638- 1646

(6)Madempudi RS, Neelamraju J, Ahire JJ, Gupta SK, Shukla VK. Bacillus coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study. Probiotics Antimicrob Proteins. 2020;12(2):335-342. doi:10.1007/s12602-019-09542-9

(7)Szymański H, Armańska M, Kowalska-Duplaga K, Szajewska H. Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial. Digestion. 2008;78(1):13-17. doi:10.1159/000151300

(8)Engelbrektson, Anna & Korzenik, Joshua & Pittler, Arlyn & Sanders, Mary & Klaenhammer, Todd & Leyer, Gregory & Kitts, Christopher. (2009). Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. Journal of medical microbiology. 58. 663-70. 10.1099/jmm.0.47615-0.

(9)Turner RB, Woodfolk JA, Borish L, et al. Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection – a randomised controlled trial. Benef Microbes. 2017;8(2):207-215. doi:10.3920/BM2016.0160

(10)Yang YX, He M, Hu G, et al. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World J Gastroenterol. 2008;14:6237-6243.

(11)Maldonado J, Cañabate F, Sempere L, et al. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants [published correction appears in J Pediatr Gastroenterol Nutr. 2012 Apr;54(4):571]. J Pediatr Gastroenterol Nutr. 2012;54(1):55-61. doi:10.1097/MPG.0b013e3182333f18

(12)Sur D, Manna B, Niyogi SK, et al. Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slum. Epidemiol Infect. 2011;139(6):919-926. doi:10.1017/S0950268810001780

(13)Janvier A, Malo J, Barrington KJ. Cohort study of probiotics in a North American neonatal intensive care unit [published correction appears in J Pediatr. 2014 Jun;164(6):1503]. J Pediatr. 2014;164(5):980-985. doi:10.1016/j.jpeds.2013.11.025

(14)Latvala, S., et al. “Health Benefits of a Combination Probiotics; FlorMidabil[TM].” International Journal of Probiotics & Prebiotics, vol. 14, 2019, p. 9+. Gale Academic OneFile

(15)Paineau, Damien & Carcano, Didier & Leyer, Gregory & Darquy, Sylviane & Alyanakian, Marie-Alexandra & Simoneau, Guy & Bergmann, Jean-François & Brassart, Dominique & Bornet, Francis R. J. & Ouwehand, Arthur. (2008). Effects of seven potential probiotic strains on specific immune responses in healthy adults: A double-blind, randomized, controlled trial. FEMS immunology and medical microbiology. 53. 107-13. 10.1111/j.1574-695X.2008.00413.x.

(16)García Trallero O, Herrera Serrano L, Bibián Inglés M, Roche Vallés D, Rodríguez AM. Effect of the administration of a probiotic with a combination of Lactobacillus and Bifidobacterium strains on antibiotic-associated diarrhea. Rev Esp Quimioter. 2019;32(3):268-272.

(17) Ouwehand AC, DongLian C, Weijian X, Stewart M, Ni J, Stewart T, et al. Probiotics reduce symptoms of antibiotic use in a hospital setting: A randomized dose response study. Vaccine. 2014;32:458–463. doi: 10.1016/j.vaccine.2013.11.053. 

(18)Nagpal, Ravinder & Kaur, Varinder & Kumar, Manoj & Marotta, Francesco. (2013). Effect of Aloe vera juice on growth & activities of Lactobacilli in-vitro. Acta bio-medica: Atenei Parmensis. 83. 183-188.

(19)Cuvas, Ruth & Julio, Montañez & Contreras-Esquivel, Juan & Mario, Cruz & Mussatto, Solange & Belmares, Ruth. (2016). Aloe vera and Probiotics: A New Alternative to Symbiotic Functional Foods. Annual Research & Review in Biology. 9. 1-11. 10.9734/ARRB/2016/22622.

(20)O’Mahony L. et al (2005), ‘Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles, Gastroenterology, 128(3):541-51.

(21)Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999;135(5):564-568. doi:10.1016/s0022-3476(99)70053-3

(22)Cazzola M, Pham-Thi N, Kerihuel JC, Durand H, Bohbot S. Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study. Ther Adv Respir Dis. 2010;4(5):271-278. doi:10.1177/1753465810379010

(23)Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol. 2001;108(1):144-145. doi:10.1067/mai.2001.115754

(24)Acidophilus Milk Products: A Review of Potential Benefits to Consumers Gilliland S.E.(1989) Journal of Dairy Science, 72 (10) , pp. 2483-2494.

(25) Lee Y. and Salminen S., (2009), Handbook of Probiotic and Prebiotics. 2nd edition, Hoboken: John Wiley & Sons.
Lindfors K., (2008), ‘Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture’. Clin. Exp. Immunol., 152 (3):552-558.

(26)Zupancic K, Kriksic V, Kovacevic I, Kovacevic D. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review. Probiotics Antimicrob Proteins. 2017;9(2):102-110. doi:10.1007/s12602-017-9261-2

(27)Kalman, D.S., Schwartz, H.I., Alvarez, P. et al. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms. BMC Gastroenterol 9, 85 (2009). https://doi.org/10.1186/1471-230X-9-85

(28)Rogha M, Esfahani MZ, Zargarzadeh AH. The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial. Gastroenterol Hepatol Bed Bench. 2014;7(3):156-163.

(29)Anaya-Loyola MA, Enciso-Moreno JA, Lopez-Ramos JE, Garcia-Marin G, Orozco Alvarez MY, Vega-Garcai AM, Mosqueda J, Garcia-Gutierrez DG, Keller D, Perez-Ramirez IF. Bacillus coagulans GBI-30, 6086 decreases upper respiratory and gastrointestinal tract symptoms in healthy Mexican scholar-aged children by modulating immune-related proteins. (2019) 

(30)Cui, X and Wure, G. 2003. The treatment of 62 cases of rotavirus gastroenteritis by Biostime probiotics. Chin J Gen Med 5:53-54.

(31)Jiang X. 2008. Clinical evaluation of Biostime in the treatment of children with persistent diarrhea. The 6th Chin National Conf on Pediatr Microecol 142-145.

(32)Chen L, Ouyang L-J, Liao W-J, Zhang W-H. 2007. Mucous membrane immunity enhanced by taking Biostime probiotics. Chin J Ecol 19:137-141.

(33)Cazzola M, Pham-Thi N, Kerihuel JC, Durand H, Bohbot S. 2010b. Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study. Ther Adv. Respir Dis 4:271-278.

(34)Kołodziej M, Szajewska H. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial. BMJ Open. 2017;7(1): e013928. DOI: 10.1136/bmjopen-2016-013928

(35)Francavilla, R., Lionetti, E., Castellaneta, S., Ciruzzi, F., Indrio, F., Masciale, A., Fontana, C., La Rosa, M.M., Cavallo, L. and Francavilla, A., 2012. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea – a double-blind study. Alimentary Pharmacology and Therapeutics 36: 363-369.

(36). Dinleyici EC, Dalgic N, Guven S, et al. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. J Pediatr (Rio J). 2015;91:392-396.

(37)Urbanska M, Szajewska H. The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. Eur J Pediatr. 2014;173:1327-1337.

(38)Savino F. et al., (2015), ‘Preventive effects of oral probiotic on infantile colic: a prospective, randomised, blinded, controlled trial using Lactobacillus reuteri DSM 17938’. Benef. Microbes, 6(3):245-251, ePub 8 Dec. 2014.

(39)Weizman Z, Abu-Abed J, Binsztok M. Lactobacillus reuteri DSM 17938 for the Management of Functional Abdominal Pain in Childhood: A Randomized, Double-Blind, Placebo-Controlled Trial. J Pediatr. 2016;174:160-164.e1. doi:10.1016/j.jpeds.2016.04.003

(40)Kawahara T, Makizaki Y, Oikawa Y, et al. Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors. PLoS One. 2017;12(3):e0173979. Published 2017 Mar 27. doi:10.1371/journal.pone.0173979

(41)M. Margreiter, K. Ludl, W. Phleps and S.T. Kaehler.Therapeutic value of a Lactobacillus gasseri and Bifidobacterium longum fixed bacterium combination in acute diarrhea: a randomized, double-blind, controlled clinical trial. 2006; 44: 207-215. doi: 10.5414/CPP44207.

(42)Jennifer C Dennis-Wall, Tyler Culpepper, Carmelo Nieves, Jr., Cassie C Rowe, Alyssa M Burns, Carley T Rusch, Ashton Federico, Maria Ukhanova, Sheldon Waugh, Volker Mai, Mary C Christman, Bobbi Langkamp-Henken, Probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial, The American Journal of Clinical Nutrition, Volume 105, Issue 3, March 2017, Pages 758–767,

(43)Mack D.R. et al., (2003), ‘Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro’. Gut, 52:827-33.

(44)Thijssen A.Y. et al., (2011), ‘A randomized, placebo-controlled double blind study to assess the efficacy of a probiotic dairy product containing Lactobacillus casei Shirota on symptoms of irritable bowel syndrome’. Gastroenterology, 140(5,S1):S609.

(45)Koebnick C. et al., (2003), ‘Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation’. Canadian Journal of Gastroenterology, 17(11):655 – 659.

(46) Hickson M, D’Souza AL, Muthu N, et al. Use of probiotic Lactobacilluspreparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007;335:80.

(47)Cionci N e et al. (2018). Therapeutic Microbiology: The role of Bifidobacterium breve as food supplement for the prevention/treatment of paediatric diseases. Nutrients , 10 (11): 1723 .